🇺🇸 FDA
Patent

US 7994178

Crystalline rosuvastatin calcium and compositions thereof for treatment of hyperlipidaemia

granted A61PA61P3/06A61P43/00

Quick answer

US patent 7994178 (Crystalline rosuvastatin calcium and compositions thereof for treatment of hyperlipidaemia) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61P, A61P3/06, A61P43/00, A61P9/00